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During the periparturient period (3 wk before calving to 3 wk after calving) dairy cows 
commonly experience a negative energy balance due to the increased nutrient requirements for 
fetal growth and milk production coupled with decreased dry matter intake (DMI). This 
combination can increase the risk of developing certain immunologic problems and metabolic 
disorders like oxidative stress, ketosis, and fatty liver. Two experiments were conducted to 
evaluate 1) hepatic microRNA (miRNA) involvement in periparturient Holstein dairy cows 
supplemented methionine and 2) how body condition score (BCS) in late pregnancy impacts 
hepatic biomarkers involved in energy metabolism.  
Previous in silico work relevant to fatty liver disease and ketosis revealed miRNAs may 
play a role in variety of important biological pathways including, fatty acid metabolism (miR-
186, -200b and c, -218, -369) and oxidative phosphorylation (miR-101, -142, -186, -200b, -200c, 
-218, and -369). The main objective of the present study was to verify the expression of these 
miRNA and examine the relationship they may have in cows supplemented methionine during 
the peripartal period. Nineteen multiparous Holstein cows were fed experimental treatments 
consisting of a basal control diet (CON; n = 11) and CON plus Methionine (MET; n = 8). (at a 
rate of 0.08% on a dry matter basis) (Smartamine M, Adisseo NA). All cows received the same 
far-off, close-up, and lactation diet. Liver biopsies were performed at −10, 10, and 30 d relative 
to calving for analysis of miR-218, miR-369 5p, miR-200b, miR-200c, miR-142 3p, miR-142 5p, 
miR-101, and miR-186 abundance via qPCR after normalization with 3 internal controls. Results 
indicated that MET cows had less expression of miRNAs that were predicted to downregulate 
oxidative phosphorylation and fatty acid metabolism, compared to CON. Considering that MET 
cows had greater overall DMI there is a possibility that they were experiencing less oxidative 
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stress in the liver, as opposed to CON, but the relationship is still unclear. Further analysis of 
gene targets and protein expression relevant to miRNAs presented in this study will provide 
more insight into the biological importance of miRNAs. 
In the second study, twenty-six multiparous Holstein cows at 4 wk were divided into 2 
groups based on BCS, BCS ≥ 3.50 (n = 13; HiBCS) and BCS ≤ 3.25 (n = 13; LoBCS). In the 
prepartum, LoBCS cows had greater DMI compared to HiBCS cows (P = 0.06). In the 
postpartum, LoBCS continued to have greater DMI, but HiBCS cows averaged 5.34 kg/d greater 
in milk yield comparatively. Plasma sampled at d −30, −10, 7, 15, and 30, relative to calving 
indicated increased concentrations of biomarkers related to negative energy balance in HiBCS 
cows. In contrast, LoBCS had greater plasma concentrations of biomarkers that have antioxidant 
properties, thus suggesting a potential relationship with oxidative stress. Liver tissue harvested 
via biopsy at −15, 7, and 30 d relative to calving and used to evaluate protein abundance via 
western blotting. We were unable to detect any expression of nuclear factor erythroid 2-like 2 
(NFE2L2) or p-NFE2L2 (both are involved in antioxidant signaling pathways) at any time point 
in liver tissue. However, LoBCS cows had increased abundance of proteins associated with 
glutathione metabolism, an antioxidant that is capable of preventing overloads of reactive 
oxygen species (ROS), compared with HiBCS. miR-369 5p, miR-186, and miR-200b, which 
downregulate fatty acid metabolism and oxidative phosphorylation, had decreased expression in 
HiBCS cows, which is contrary to the patterns of decreased oxidative stress in LoBCS cows we 
observed in plasma biomarkers and protein abundance. In conclusion, the differences between 
production data, blood biomarkers, miRNA expression, and protein abundance underscore a 
potentially important interaction between energy metabolism in relation to BCS during the 
periparturient period.    
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CHAPTER 1: INTRODUCTION 
The periparturient period, or transition period (3 wks before calving to 3 wks after 
calving), indicates the life stage where a dairy cow moves from late pregnancy to early lactation  
(Grummer, 1995). After parturition, dairy cows are disposed to experience an imbalance between 
the production of free radicals and their elimination by antioxidants, which is also referred to as 
oxidative stress (Sordillo and Aitken, 2009). Antioxidants, like glutathione reduce the levels of 
reactive oxygen species to prevent free radical damage (Bayir, 2005). Additionally, the 
inflammatory events that afflict cows during early lactation are associated with physiologically 
stressful conditions and the metabolic overload of the liver to meet the nutrient requirements for 
maintenance and milk synthesis also referred to as negative energy balance (NEB) (Bertoni, 
2015). NEB can lead to hepatic lipidosis which results from excessive accumulation of 
triacylglycerol (TAG) in the liver, thus impairing normal functions (Bell, 1995, Drackley, 1999). 
This underscores the role that fatty acid metabolism and oxidative phosphorylation play in dairy 
cows as they transition from pregnancy to lactation.  
There is evidence that when supplementing methionine (a limiting amino acid for milk 
synthesis) in the diet, cows will have decreased incidences of metabolic disorders and improved 
immune function (Schwab et al., 1992, Lima et al., 2012, Zhou et al., 2016, Batistel et al., 2017). 
The supplementation of methionine during the transition period has also improved milk yield, 
milk protein, and increased antioxidant synthesis (Schmidt et al., 1999, Osorio et al., 2013). All-
in-all, methionine supplementation is associated with improved hepatic lipid metabolism in dairy 
cows (Durand, 1992).  
 Body condition score (BCS) is a useful measure of animal health as it reflects both the 
amount of subcutaneous fat in the body and indicates the nutritional status of a dairy cow (Roche 
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et al., 2009). In the United States, BCS are evaluated on a 5-point scale, where 1 indicates a thin 
or emaciated cow, while a 5 equates to an over-conditioned obese cow (Roche et al., 2004, 
Roche et al., 2009). At calving, if a cow has a more optimal BCS this could promote a successful 
transition period and maximize production in the postpartum (Akbar et al., 2015). Cows with 
higher BCS are at a greater risk of developing fatty liver disease or ketosis and are under more 
oxidative stress during the transition period (Reid et al., 1986, Bernabucci et al., 2005, Schulz et 
al., 2014). Therefore, BCS has a close relationship with metabolic disorders and is a useful tool 
in dairy cow management. 
Another emerging tool to evaluate health of an animal are microRNAs (miRNAs). 
miRNAs are short non-coding RNAs of 22 nucleotides in length that regulate gene expression 
post-transcriptionally (Ruby et al., 2007). miRNAs are believed to play a role in fat cell 
formation (adipogenesis) (Jin et al., 2009, Jin et al., 2010). Additionally, miRNA targets related 
to adipogenesis and inflammation are involved in miRNA signaling through networks involving 
transcription factors, suggesting a possible role in the control of inflammation (Arner and Kulyte, 
2015).  
The main objective of the first study was to verify the expression of miRNA predicted (in 
silico) to play a role in energy metabolism and examine the relationship they may have in cows 
supplemented methionine during the peripartal period. The aim of the second study was to 
further verify the previously mentioned miRNA and identify any associations between body 
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CHAPTER 2: LITERATURE REVIEW 
The Transition Period 
 The life stage where dairy cows shift from late pregnancy to early lactation is widely 
referred to as the transition period or periparturient period. However, the duration a cow spends 
in this transition is described differently by different authors. Most commonly the period is 
classified as 3 weeks prior to parturition and 3 weeks after parturition (Grummer, 1995). 
The transition period was described perfectly by Goff (1977), as “too often a disastrous 
experience for the cow”. Usually, around 3 weeks before calving a gradual but significant 
decrease in dry matter intake (DMI) can be observed in dairy cows (Bertics et al., 1992, 
Drackley, 1999). A potential explanation for decreased DMI is tremendous fetal growth during 
the last few weeks of gestation. Thus, ruminal capacity can reduce as much as 20%, limiting the 
amount of feed a cow can consume (Spain, 2002). However, many other factors can influence 
intake like body condition score (BCS), parity, milk yield, and nutrient composition of the diet 
(Allen, 2000, Bell et al., 2000). If this trend of DMI proceeds into the lactation period, cows can 
enter a negative nutrient balance as demands for energy and nutrients increase for colostrum and 
milk synthesis (Ferguson, 2005). A poor transition from pregnancy to lactation usually results in 
the loss of 4-9 kg of peak milk yield. In the long run, this could equate to 900-1800 kg of 
unusable milk (Wallace, 1996). Unfortunately, these losses translate to decreased profits for 
producers.     
Parturition is marked by an increased risk for metabolic disorders (such as milk fever, 
displaced abomasum, fatty liver, and ketosis), infectious diseases (mastitis and udder edema), 
and reproductive difficulties (dystocia, retained placenta, uterine infections) making it the most 
critical physiological stage a cow may face (Drackley, 1999). The occurrence of metabolic 
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disorders is linked to decreased feed intake and milk production (Bertics et al., 1992). 
Importance exponentially increases when considering the ramifications disease during the 
transition period may have on future pregnancies and lactations. Identifying and treating diseases 
early, potentially as early as the prepartum, may be beneficial in overcoming future production 
losses (Huzzey et al., 2011). Therefore, the transition period is a crucial time for producers to 
monitor an animal’s health.  
Liver and Energy Metabolism  
As dairy cows transition from pregnancy to lactation, nutrient supplies become depleted, 
causing a large amount of non-esterified fatty acids (NEFA) to mobilize from adipose tissue 
(Bell, 1995). This is primarily due to the increased nutrient requirements for milk production and 
fetal development, at a time when dry matter intake (DMI) or nutrient supply, is not adequate 
(Bell, 1995). The disproportion of supply vs. demand leads to a period of negative energy 
balance (NEB). The liver will take up the mobilized NEFA from adipose for β-oxidation in the 
mitochondria to create metabolites, like acetyl-CoA, which will be used to generate energy in the 
Krebs cycle. If not oxidized, the excess NEFA are repackaged into triacylglycerol (TAG) and 
exported as very low-density lipoprotein (VLDL). However, the liver has a threshold limiting the 
amount of NEFA that can be metabolized into TAG. Hepatic lipidosis results from excessive 
accumulation of TAG in the liver which ultimately impairs normal function. When the maximum 
is reached, the TAG accumulates in the liver, and acetyl CoA that are not utilized are converted 
into ketone bodies, like beta-hydroxybutyrate (BHB). When ketones are produced in excess of 
the tissue's ability to use them, they accumulate in the blood, which in severe cases can lead to 
ketosis (Bell, 1995, Drackley, 1999).  
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The enzymes that regulate hepatic fatty acid metabolism are subject to hormonal control 
from insulin and glucagon. A low insulin/glucagon ratio can stimulate lipolysis in adipose tissues 
and ketogenesis in the liver allowing cows to adapt to different nutritional and physiological 
conditions (Holtenius and Holtenius, 1996). For example, increased insulin reduces carnitine 
palmitoyltransferase I (CPTI) activity which will lead to decreased NEFA transport into 
mitochondria, thereby suppressing ketogenesis (McGarry and Foster, 1980). Although, increased 
insulin can also promote esterification and more synthesis of triglyceride (Keller et al., 1988). 
Body Condition Score (BCS) 
In previous studies from the early 1990s, body weight alone was the primary tool for 
measuring fat reserves in a cow. However, body weight does not encompass all indicators of 
body reserves such as, parity, stage of lactation, frame size, gestation, and breed (Roche et al., 
2009). Additionally, increases in body weight can be falsely enhanced by gastrointestinal fill. 
Body condition score (BCS) is a useful tool as it reflects both the amount of subcutaneous fat in 
the body and indicates the nutritional status of an animal (Roche et al., 2009). The first scoring 
system was introduced by Lowman (1973) which was based introduced on a 4-point scale in beef 
cattle. Today, there are many differences in international scoring systems ranging from a 5-point 
scale to a 10-point scale so a conversion method was created by Roche et al. (2004). In the 
United States, BCS are evaluated on a 5-point scale, where 1 indicates a thin or emaciated cow, 
while a 5 equates to an over-conditioned obese cow (Roche et al., 2004). At calving, if a cow has 
a more optimal BCS this could promote a successful transition period and maximize production 
in the postpartum (Akbar et al., 2015). Cows with higher BCS are at a greater risk of developing 
fatty liver disease or ketosis and are under more oxidative stress during the transition period 
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(Reid et al., 1986, Bernabucci et al., 2005, Schulz et al., 2014). Thus, BCS has a close 
relationship with metabolic disorders and is a useful tool in dairy cow management. 
Oxidative Phosphorylation 
 Oxidative phosphorylation begins with an electron transfer chain driven by substrate 
oxidation, coupled with ATP synthesis through an electrochemical transmembrane gradient 
(Papa et al., 2012). While this process is essential in creating energy for various biological 
functions, it also produces reactive oxygen species (ROS) or free radicals (Wallace et al., 1992). 
ROS is highly reactive and can interact and destroy, DNA, proteins, and lipids. Antioxidants, 
like glutathione, reduce the levels of ROS to prevent free radical damage (Bayir, 2005). When 
the rate at which ROS can be removed or repaired becomes imbalanced, oxidative stress and 
inflammation can begin.  
In nonruminants, nuclear factor erythroid 2-like 2 (NFE2L2) (formerly known as Nrf2), 
is a key transcription factor that controls oxidative stress by increasing the concentration of 
antioxidant enzymes, a mechanism of critical importance for cellular protection and survival 
(Kaspar et al., 2009). Glutathione (GSH) is a crucial antioxidant in mammalian cell and the GSH 
metabolism pathway is one of the target pathways regulated by NFE2L2. In mammary epithelial 
cell culture, several antioxidants activate NFE2L2, causing an increase in the transcription of 
antioxidants overall (Jin et al., 2016). In summation, this suggests that both NFE2L2 and GSH, 
play a key role in regulating antioxidant networks. 
Methionine 
Methionine is a limiting amino acid for milk synthesis in dairy cows making it an 
important area of focus, especially surrounding parturition (Schwab et al., 1992). Moreover, 
methionine has a role in processes in the liver like one-carbon metabolism and synthesis of GSH 
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(Martinov et al., 2010). Previous research supported that methionine supplementation led to a 
decreased risk of metabolic disorders and improved immune function (Lima et al., 2012, Zhou et 
al., 2016). The supplementation of rumen-protected methionine during the transition period has 
also improved milk yield, milk protein, and increased antioxidant synthesis (Schmidt et al., 1999, 
Osorio et al., 2013). Additionally, methionine supplementation has been associated with overall 
improved hepatic lipid metabolism in dairy cows (Durand, 1992). A recent study found that in 
the mammary tissue of cows supplemented methionine, genes related to GSH 
(GCLC, GCLM, GSR, GPX1, and ME1) metabolism were upregulated, suggesting that amino 
acids play a role in regulating oxidative stress by controlling GSH metabolism in mammary cells 
(Han et al., 2018). Most likely because methionine plays a role in one-carbon metabolism in liver 
and is a source of cysteine, the limiting reagent for synthesis of GSH (Martinov et al., 2010, 
Zhou et al., 2017). 
MicroRNAs (miRNAs) 
 It is speculated that the human genome encodes around 1000 miRNAs which equate to 
the regulation of about one-third of all human genes. miRNAs are short non-coding RNAs of 22 
nucleotides in length that regulate gene expression post-transcriptionally by binding to the 3’ 
untranslated region of a target mRNA (Ruby et al., 2007). Binding of the miRNA will lead to 
translational repression, target degradation, and gene silencing (Bartel, 2009).  
 The role of miRNAs in lipid metabolism was first examined in fruit flies (Drosophila), 
where the deletion of miR-14 resulted in increased levels of triacylglycerol and diacylglycerol 
(Xu et al., 2003). Since then, more miRNAs were shown to play a role in fat cell formation 
(adipogenesis). Beef cattle adipose miRNA profiling was recently correlated with fat deposit 
location and function, supporting the importance of miRNA (miR-378 and miR-143) in 
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regulating adipocyte metabolism (Jin et al., 2009, Jin et al., 2010). Another study investigated 
miRNA targets related to adipogenesis and inflammation and found adipocyte metabolic 
pathways are controlled by miRNA signaling through networks involving transcription factors, 
suggesting a possible role in the control of inflammation (Arner and Kulyte, 2015).  
Furthermore, miRNA research in human clinical trials is an expanding field. Researchers 
found that miR-122 had an impact on lipid metabolism, but also the destruction of it which 
increased inflammation, leading to a poor prognosis of liver cancer (Hsu et al., 2012). Similarly, 
miRNA expression in humans has been associated with increased cytokine development and a 
greater degree of immune cell infiltration (Kloting et al., 2009). Additionally, miRNAs in serum 
may be a better biomarker to assess early non-alcoholic fatty liver as opposed to other popular 
clinical models (Iravani et al., 2018). Though the amount of literature about miRNAs has 
increased substantially in the past sixteen years, more experimentation (from both clinical trials 





Akbar, H., T. M. Grala, M. Vailati Riboni, F. C. Cardoso, G. Verkerk, J. McGowan, K. 
Macdonald, J. Webster, K. Schutz, S. Meier, L. Matthews, J. R. Roche, and J. J. Loor. 
2015. Body condition score at calving affects systemic and hepatic transcriptome 
indicators of inflammation and nutrient metabolism in grazing dairy cows. J Dairy Sci 
98(2):1019-1032. 
Allen, M. S. 2000. Effects of diet on short-term regulation of feed intake by lactating dairy cattle. 
J Dairy Sci 83(7):1598-1624. 
Arner, P. and A. Kulyte. 2015. MicroRNA regulatory networks in human adipose tissue and 
obesity. Nat Rev Endocrinol 11(5):276-288. 
Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136(2):215-
233. 
Bayir, H. 2005. Reactive oxygen species. Crit Care Med 33(12 Suppl):S498-501. 
Bell, A. W. 1995. Regulation of organic nutrient metabolism during transition from late 
pregnancy to early lactation. J Anim Sci 73(9):2804-2819. 
Bell, A. W., W. S. Burhans, and T. R. Overton. 2000. Protein nutrition in late pregnancy, 
maternal protein reserves and lactation performance in dairy cows. Proc Nutr Soc 
59(1):119-126. 
Bernabucci, U., B. Ronchi, N. Lacetera, and A. Nardone. 2005. Influence of body condition 
score on relationships between metabolic status and oxidative stress in periparturient 
dairy cows. J. Dairy Sci. 88(6):2017-2026. 
 13 
Bertics, S. J., R. R. Grummer, C. Cadorniga-Valino, and E. E. Stoddard. 1992. Effect of 
prepartum dry matter intake on liver triglyceride concentration and early lactation. J 
Dairy Sci 75(7):1914-1922. 
Drackley, J. K. 1999. ADSA Foundation Scholar Award. Biology of dairy cows during the 
transition period: the final frontier? J Dairy Sci 82(11):2259-2273. 
Durand, D., Y. Chilliard, and D. Bauchart. 1992. Effect of lysine and methionine on in vivo 
hepatic secretion of VLDL in the high yield- ing dairy cow. J. Dairy Sci 
25(Suppl.1)(279). 
Ferguson, J. D. 2005. Nutrition and reproduction in dairy herds. Vet Clin North Am Food Anim 
Pract 21(2):325-347. 
Goff, J. P. a. R. L. H. 1977. Physiological changes at parturition and their relationship to 
metabolic disorders. Journal of dairy science 80(7):1260-1268. 
Grummer, R. R. 1995. Impact of changes in organic nutrient metabolism on feeding the 
transition dairy cow. J Anim Sci 73(9):2820-2833. 
Han, L., F. Batistel, Y. Ma, A. S. M. Alharthi, C. Parys, and J. J. Loor. 2018. Methionine supply 
alters mammary gland antioxidant gene networks via phosphorylation of nuclear factor 
erythroid 2-like 2 (NFE2L2) protein in dairy cows during the periparturient period. J 
Dairy Sci 101(9):8505-8512. 
Holtenius, P. and K. Holtenius. 1996. New aspects of ketone bodies in energy metabolism of 
dairy cows: a review. Zentralbl Veterinarmed A 43(10):579-587. 
Hsu, S. H., B. Wang, J. Kota, J. Yu, S. Costinean, H. Kutay, L. Yu, S. Bai, K. La Perle, R. R. 
Chivukula, H. Mao, M. Wei, K. R. Clark, J. R. Mendell, M. A. Caligiuri, S. T. Jacob, J. 
 14 
T. Mendell, and K. Ghoshal. 2012. Essential metabolic, anti-inflammatory, and anti-
tumorigenic functions of miR-122 in liver. J Clin Invest 122(8):2871-2883. 
Huzzey, J. M., D. V. Nydam, R. J. Grant, and T. R. Overton. 2011. Associations of prepartum 
plasma cortisol, haptoglobin, fecal cortisol metabolites, and nonesterified fatty acids with 
postpartum health status in Holstein dairy cows. J Dairy Sci 94(12):5878-5889. 
Iravani, F., N. Hosseini, and M. Mojarrad. 2018. Role of MicroRNAs in Pathophysiology of 
Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Middle East J Dig 
Dis 10(4):213-219. 
Jin, W., M. V. Dodson, S. S. Moore, J. A. Basarab, and L. L. Guan. 2010. Characterization of 
microRNA expression in bovine adipose tissues: a potential regulatory mechanism of 
subcutaneous adipose tissue development. BMC Mol Biol 11:29. 
Jin, W., J. R. Grant, P. Stothard, S. S. Moore, and L. L. Guan. 2009. Characterization of bovine 
miRNAs by sequencing and bioinformatics analysis. BMC Mol Biol 10:90. 
Jin, X. L., K. Wang, L. Liu, H. Y. Liu, F. Q. Zhao, and J. X. Liu. 2016. Nuclear factor-like factor 
2-antioxidant response element signaling activation by tert-butylhydroquinone attenuates 
acute heat stress in bovine mammary epithelial cells. J Dairy Sci 99(11):9094-9103. 
Kaspar, J. W., S. K. Niture, and A. K. Jaiswal. 2009. Nrf2:INrf2 (Keap1) signaling in oxidative 
stress. Free Radic Biol Med 47(9):1304-1309. 
Keller, U., P. P. Gerber, and W. Stauffacher. 1988. Fatty acid-independent inhibition of hepatic 
ketone body production by insulin in humans. Am J Physiol 254(6 Pt 1):E694-699. 
Kloting, N., S. Berthold, P. Kovacs, M. R. Schon, M. Fasshauer, K. Ruschke, M. Stumvoll, and 
M. Bluher. 2009. MicroRNA expression in human omental and subcutaneous adipose 
tissue. PLoS One 4(3):e4699. 
 15 
Lima, F. S., M. F. Sa Filho, L. F. Greco, and J. E. Santos. 2012. Effects of feeding rumen-
protected choline on incidence of diseases and reproduction of dairy cows. Vet J 
193(1):140-145. 
Lowman, B. G., N. Scott, and S. Somerville. 1973. Condition scoring of cattle. East of Scotland 
College of Agriculture, Bulletin No. 6, Edinburgh, UK. 
Martinov, M. V., V. M. Vitvitsky, R. Banerjee, and F. I. Ataullakhanov. 2010. The logic of the 
hepatic methionine metabolic cycle. Biochim Biophys Acta 1804(1):89-96. 
McGarry, J. D. and D. W. Foster. 1980. Regulation of hepatic fatty acid oxidation and ketone 
body production. Annu Rev Biochem 49:395-420. 
Osorio, J. S., P. Ji, J. K. Drackley, D. Luchini, and J. J. Loor. 2013. Supplemental Smartamine M 
or MetaSmart during the transition period benefits postpartal cow performance and blood 
neutrophil function. J Dairy Sci 96(10):6248-6263. 
Papa, S., P. L. Martino, G. Capitanio, A. Gaballo, D. De Rasmo, A. Signorile, and V. 
Petruzzella. 2012. The oxidative phosphorylation system in mammalian mitochondria. 
Adv Exp Med Biol 942:3-37. 
Reid, I., C. Roberts, R. Treacher, and L. Williams. 1986. Effect of body condition at calving on 
tissue mobilization, development of fatty liver and blood chemistry of dairy cows. 
Animal Science 43(1):7-15. 
Roche, J. R., P. G. Dillon, C. R. Stockdale, L. H. Baumgard, and M. J. VanBaale. 2004. 
Relationships among international body condition scoring systems. J Dairy Sci 
87(9):3076-3079. 
 16 
Roche, J. R., N. C. Friggens, J. K. Kay, M. W. Fisher, K. J. Stafford, and D. P. Berry. 2009. 
Invited review: Body condition score and its association with dairy cow productivity, 
health, and welfare. J Dairy Sci 92(12):5769-5801. 
Ruby, J. G., C. H. Jan, and D. P. Bartel. 2007. Intronic microRNA precursors that bypass Drosha 
processing. Nature 448(7149):83-86. 
Schmidt, J., P. Sipocz, E. Cenkvari, and J. Sipocz. 1999. Use of protected methionine (Mepron 
M 85) in cattle. Acta Vet Hung 47(4):409-418. 
Schulz, K., J. Frahm, U. Meyer, S. Kersten, D. Reiche, J. Rehage, and S. Dänicke. 2014. Effects 
of prepartal body condition score and peripartal energy supply of dairy cows on 
postpartal lipolysis, energy balance and ketogenesis: an animal model to investigate 
subclinical ketosis. JDR 81(3):257-266. 
Schwab, C. G., C. K. Bozak, N. L. Whitehouse, and M. M. Mesbah. 1992. Amino acid limitation 
and flow to duodenum at four stages of lactation. 1. Sequence of lysine and methionine 
limitation. J Dairy Sci 75(12):3486-3502. 
Spain, J. N. a. W. A. S. 2002. The 100-day contract with the dairy cow: 30 days prepartum to 70 
days postpartum. Advances in dairy technology 14:19-42. 
Wallace, D. C., J. M. Shoffner, R. L. Watts, J. L. Juncos, and A. Torroni. 1992. Mitochondrial 
oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 32(1):113-114. 
Wallace, R. L., G. C. McCoy, T. R. Overton, and J. H. Clark. 1996. Effect of adverse health 
events on dry matter consumption, milk production, and body weight loss of dairy cows 
during early lactation. Journal of dairy science 79 Suppl 1. 
Xu, P., S. Y. Vernooy, M. Guo, and B. A. Hay. 2003. The Drosophila microRNA Mir-14 
suppresses cell death and is required for normal fat metabolism. Curr Biol 13(9):790-795. 
 17 
Zhou, Z., T. A. Garrow, X. Dong, D. N. Luchini, and J. J. Loor. 2017. Hepatic Activity and 
Transcription of Betaine-Homocysteine Methyltransferase, Methionine Synthase, and 
Cystathionine Synthase in Periparturient Dairy Cows Are Altered to Different Extents by 
Supply of Methionine and Choline. J Nutr 147(1):11-19. 
Zhou, Z., M. Vailati-Riboni, E. Trevisi, J. K. Drackley, D. N. Luchini, and J. J. Loor. 2016. 
Better postpartal performance in dairy cows supplemented with rumen-protected 
methionine compared with choline during the peripartal period. J Dairy Sci 99(11):8716-
8732. 
 18 
CHAPTER 3: HEPATIC MICRORNA INVOLVEMENT IN PERIPARTURIENT 
HOLSTEIN DAIRY COWS SUPPLEMENTED METHIONINE 
ABSTRACT 
During the peripartal period (3 wk before calving to 3 wk after calving) dairy cows are at 
risk for entering a negative energy balance which can increase the risk of developing metabolic 
disorders like ketosis or fatty liver. Methionine supplementation in peripartal diets may be 
beneficial in combatting diseases dairy cows are prone to during the transition period. Previous 
in silico work relevant to fatty liver disease and ketosis revealed microRNAs (miRNAs) may 
play a role in fatty acid metabolism (miR-186, -200b and c, -218, -369), oxidative 
phosphorylation (miR-101, -142, -186, -200b, -200c, -218, and -369), peroxisome (miR-186, -
200b and c), gluconeogenesis (miR-186, -369), peroxisome proliferator-activator receptor 
(PPAR) signaling pathway (miR-101, -142, -186, -200b and c), insulin signaling pathway (miR-
186, -200b, -218, -369), and apoptosis (miR-142, -200b, -369). The main objective of the present 
study was to verify the expression of these miRNA in liver and examine the relationship they 
may have in cows supplemented methionine during the peripartal period. Nineteen multiparous 
Holstein cows were fed experimental treatments consisting of a basal control diet (CON; n = 11) 
and CON plus Methionine (Smartamine M, Adisseo NA) (MET; n = 8). All cows received the 
same far-off diet from -50 to -22 d before the expected calving date, close-up diet from -21 d to 
expected calving, and lactation diet from calving through 30 days in milk (DIM). MET 
supplementation was adjusted daily from -21 d to 30 DIM at a rate of 0.08% (dry matter basis) of 
diet dry matter. Liver biopsies were performed at −10, 10, and 30 d relative to calving for 
analysis of miR-218, miR-369 5p, miR-200b, miR-200c, miR-142 3p, miR-142 5p, miR-101, 
and miR-186 abundance via qPCR after normalization with 3 internal controls. Data were 
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subjected to repeated measures ANOVA in SAS using PROC MIXED. The main effects were 
treatment (CON or MET), time, and their interaction, while cow was the random effect. We 
observed a significant treatment × time effect for miR-186 (P ≤ 0.05), associated with less 
expression in MET compared with CON cows on d -10, which may suggest that MET cows 
downregulated fatty acid metabolism and oxidative stress. A significant time effect was present 
in miR-369 5p and miR-200b expression (P ≤ 0.05) which both were predicted to down regulate 
oxidative phosphorylation, but the relationship between these miRNAs and the pathways they 
affect need to be studied more. miR-186 had the most promise for future studies that could 
determine the role it plays in energy metabolism, as it has the most interaction with overlapping 
biological pathways. Overall, miRNAs are expressed in the liver of cows supplemented 
methionine, however analyses of gene targets of these miRNA along with protein expression will 
provide more insight to the biological relevance. 
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INTRODUCTION 
The periparturient period (3 wk before calving to 3 wk after calving), or transition period, 
is critically important to the health, production, and profitability of dairy cows (Drackley, 1999). 
During this time, cows are most susceptible to metabolic disorders and immunologic challenges 
such as oxidative stress, ketosis, and fatty liver disease. This is primarily due to the increased 
nutrient requirements for milk production and fetal development, at a time when dry matter 
intake (DMI) or nutrient supply, is inadequate (Bell, 1995). The disproportion of supply vs. 
demand leads to a period of negative energy balance (NEB), disrupting fatty acid metabolism. 
When nutrient supply is depleted, adipose tissue mobilizes non-esterified fatty acids (NEFA) 
which originate from the hydrolysis of triacylglycerol (TAG). Hepatic lipidosis results from 
excessive accumulation of TAG in the liver which ultimately impairs normal function. 
Additionally, when ketones are produced in excess of the peripheral tissue's capacity to use 
them, they accumulate in the bloodstream, leading to ketosis in severe cases (Bell, 1995, 
Drackley, 1999). When dairy cows are affected by these two diseases they exhibit clinical 
symptoms including reduced feed intake, decreased milk yield, body weight loss, staggering, 
lack of coordination, and blindness (Mulligan and Doherty, 2008).   
Previous research exists that links amino acid supplementation to a decreased risk of 
metabolic disorders, like ketosis and fatty liver disease (Lima et al., 2012, Zhou et al., 2016). 
Methionine is a limiting amino acid for milk synthesis in dairy cows making it an important area 
of focus, especially surrounding parturition (Schwab et al., 1992). In previous studies, the 
supplementation of rumen-protected methionine during the transition period has improved milk 
yield, milk protein, and postpartum immune function (Schmidt et al., 1999, Osorio et al., 2013). 
Additionally, methionine supplementation has been associated with improved hepatic lipid 
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metabolism in dairy cows (Durand, 1992). Therefore, it is possible that supplementation of 
methionine could reduce elevated fatty acids in the liver, contributing to a decrease in the 
incidence of fatty liver and ketosis.  
microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression 
extensively (Iravani et al., 2018). In humans, miRNome profiling provided insights into the 
molecular mechanisms involved in nonalcoholic fatty liver disease (Cheung et al., 2008, Alisi et 
al., 2011). However, (to our knowledge) the application of miRNome profiling in dairy cows 
developing fatty liver disease is unknown. To better understand the possible role miRNA play 
during the onset of fatty liver in transition cows, Vailati-Riboni (2017), applied an in-silico 
approach to locate a signature of miRNA activation from transcriptomics data. The transcriptome 
database was created from an experiment by Loor et al. (2007). Briefly, ketosis and fatty liver 
were induced in cows fed at 50% feed restriction from day 5 until 14 d relative to calving, or 
until clinical signs of ketosis (anorexia, ataxia, or abnormal behavior) were observed. Liver 
tissue (n = 7/group) for gene expression profiling was sampled at the onset of signs of clinical 
ketosis or d 14 postpartum for control cows. Initially, a list of miRNA families and their 
predicted target genes for Bos taurus were downloaded from the Microcosm targets website (v. 
5.0). Results for the effect of ketosis were then used to predict miRNA activity from the mRNA 
expression profiles through 3 approaches described by Arora (2008): Wilcoxon rank test, Ranked 
Ratio, and Mean absolute expression. After overlapping the results of the 3 approaches, a total of 
7 miRNA were predicted as possible components in the transcriptomic response associated with 
ketosis and fatty liver: miR-101, miR-142, miR-186, miR-200b, miR-200c, miR-218, and miR-
369–5p. To identify miRNA functions, the dynamic impact approach (DIA), described by 
Bionaz et al. (2012), was then used for biological pathway analysis on the compiled differentially 
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expressed target genes of the predicted miRNA. Pathway analysis relevant to fatty liver revealed 
these miRNAs may play a role in fatty acid metabolism (miR-186, -200b and c, -218, -369), 
oxidative phosphorylation (all 8 miRNA), peroxisome (miR-186, -200b and c), gluconeogenesis 
(miR-186, -369), PPAR signaling pathway (miR-101, -142, -186, -200b and c), insulin signaling 
pathway (miR-186, -200b, -218, -369), and apoptosis (miR-142, -200b, -369), which is further 
detailed in Table 3.1.  
Overall, the in-silico analysis suggests that specific miRNA may be involved in the 
etiology of fatty liver through the control of key biological pathways and genes related to this 
disease (Vailati-Riboni, 2017). Thus, the main objective of the present study was to verify the 
expression of these miRNA and examine the relationship they may have in cows supplemented 
methionine during the peripartal period, particularly in fatty acid metabolism and oxidative 
phosphorylation.  
METHODS 
Experimental Design and Treatments 
All details of animal management were approved by the Animal Care and Use 
Committee at the University of Illinois (Urbana; protocol no. 14270) and have been reported 
(Batistel et al., 2017). Briefly, 60 multiparous Holstein cows (average lactation number 3.22 ± 
1.11) were assigned to a basal diet (control, n = 30) without additional Methionine or the basal 
diet with ethyl-cellulose RPM (Met, n = 30; Mepron, Evonik Nutrition and Care GmbH, Hanau-
Wolfgang, Germany) in a randomized complete block design. The RPM was top dressed from 
−28 to 60 d relative to parturition at a rate of 0.09 and 0.10% of DMI of the previous day before 
and after calving, respectively, to achieve a Lys:Met ratio of 2.8:1. The basal diet had a Lys:Met 
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ratio of 3.71:1 (prepartum) to 3.78:1 (postpartum). A Lys:Met ratio of 2.8:1 to 2.9:1 has proven 
beneficial for dairy cow production performance and health, including greater DMI and milk 
yield, better immune function, and lower incidence of ketosis postpartum (Osorio et al., 2013, 
Zhou et al., 2016). From −45 to −29 d relative to calving date, all cows were fed the same diet 
without RPM. Cows were fed once daily in the morning at 120% of expected intake and milked 
3 times daily (at 0600, 1400, and 2200 h).  Diets were formulated to meet predicted requirements 
for dairy cows according to NRC (2001) guidelines. 
Liver Biopsy 
A subset of 10 cows in the control group and 8 cows in the Met group were used for liver 
biopsies. Cows were selected based on previous 305-d milk yield, BCS, and absence of clinical 
disease. Liver tissue was harvested via puncture biopsy (Dann et al., 2005) to obtain 
approximately 4 g (wet weight) of liver. The surgical area was shaved and disinfected and the 
skin and body wall were anesthetized with 7 mL of 2% lidocaine HCl (VetOne, Boise, ID). 
Samples were collected at approximately 0800 h on d −10, 10, and 30 ± 2 d relative to 
parturition. Liver tissue was frozen immediately in liquid N and stored −80°C until further 
analysis. Health was monitored for 7 d after each procedure.  
Total RNA Extraction, Target miRNA, and qPCR 
RNA was extracted from tissue using protocols established in our laboratory (Khan et al., 
2014). Briefly, liver tissue was weighed (~0.05 g) and immediately placed in 1.2 ml of QIAzol 
reagent (Qiagen 75842; Qiagen Inc., Valencia, CA) for homogenization. After homogenization, 
DNase was used to remove any genomic DNA from RNA using RNeasy Mini Kit columns 
(Qiagen, Hilden, Germany). Concentration was measured using the Nano-Drop ND-1000 
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spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA), and the Agilent 
Bioanalyzer system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA) 
was used to measure RNA quality. miRNA-specific cDNA synthesis was performed using the 
Quanta qScript microRNA cDNA Synthesis Kit (Quanta BioSciences, Inc.), following the 
manufacturer’s protocols. The quantitative PCR (qPCR) was SYBR Green-based and performed 
as described previously by Osorio et al. (2014), using a 7-point standard curve. miRNA selected 
for expression profiling were miR-218, miR-369 5p, miR-200b, miR-200c, miR-142 3p, miR-
142 5p, miR-101, and miR-186 based on the analysis described in Figure 3.1. Internal controls 
were miR-let-7b, miR-16b and miR-181a. Measured miRNA assay primer sequence information 
and qPCR performance are included in Supplemental Table A.1. and A.2. (Appendix A). 
Percentage relative miRNA abundance in relation to the 8 miRNA targets is in Supplemental 
Figure A.1. (Appendix A). 
Statistical Analysis 
After normalization with the geometric mean of the internal control genes, miRNA qPCR 
data were log2 transformed prior to statistical analysis to obtain a normal distribution. The data 
were analyzed using the MIXED procedure of SAS v.9.4 (SAS Institute Inc., Cary, NC) 
according to the following model with repeated measures:  
Yjl = µ + Mj + Tl + MTjl + ejl, 
Where Yjl = dependent, continuous variable, µ = overall mean, Mj = fixed effect of treatment (j = 
CON vs. MET), Tl = fixed effect of time (d -10, 10, and 30 relative to parturition), MTjl = 
interaction between treatment and time, and ejl = residual error. The subject of the repeated 
statement was cow, nested within treatment, as the random effect. The Kenward-Roger statement 
was used for computing the denominator degrees of freedom, while spatial power was used as 
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the covariance structure since time intervals are not evenly spaced. Data were considered 
significant at a P ≤ 0.05 and tendencies at P ≤ 0.10 using the PDIFF statement in SAS. For ease 
of interpretation, expression data reported in tables and figures are the log2 back-transformed 
LSM that resulted from the statistical analysis. Normality of the residuals was checked with 
normal probability and box plots, and homogeneity of variances was checked with plots of 
residuals versus predicted values.  
RESULTS AND DISCUSSION 
We observed a treatment × time effect for miR-186 due to greater expression in the CON 
group at d -10 compared with MET (Fig. 3.2). Since miR-186 was predicted to downregulate 
fatty acid metabolism and oxidative stress (Fig. 3.1), MET cows potentially followed the trend of 
downregulating energy metabolism. Previously, methionine supplementation has been associated 
with improved hepatic lipid metabolism in dairy cows (Durand, 1992). Similarly, 
supplementation with rumen-protected choline and methionine promoted energy balance by 
increasing postpartal DMI and improved postpartum lactation performance, thereby enhancing 
antioxidant capacity (Sun et al., 2016). Thus, supplementation of methionine could reduce 
elevated fatty acids in the liver, contributing to a decrease in the incidence of fatty liver and 
ketosis. Our original experiment involving 60 cows reported greater DMI in the prepartum and 
postpartum in MET cows (compared to CON), but no significant differences in the incidence of 
ketosis in CON and MET cows (Batistel et al., 2017). Though, Zhou et al. (2016), found a 
tendency for cows supplemented methionine to have less incidence of ketosis during the 
transition period.  
Regarding miR-200b and miR-369 5p expression, we found significant differences in 
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time (P < 0.05), but no other differences (Fig. 3.2). Both miR-369 5p and -200b demonstrate an 
increasing trend through the transition period, with lesser expression at d -10 and greater 
expression at d 30. This could have resulted from the increasing demand for milk synthesis after 
parturition, perhaps increasing energy metabolism. Furthermore, these two miRNA were 
predicted to downregulate oxidative phosphorylation (Fig. 3.1). A recent study found that 
methionine supplementation alleviated oxidative stress in peripartal dairy cows and upregulated 
mRNA abundance related to glutathione (GSH) metabolism (Liang et al., 2019). Expression of 
miR-369 5p was significantly (P < 0.05) influenced by time, but no differences were detected 
between the interaction of treatment and time (Fig. 3.2). Another study postulated that miR-369 
5p in beef calf muscle tissue could bind to the 3′UTR of fatty acid binding protein 4 (FABP4) to 
decrease gene expression and thereby inhibit fat cell formation (adipogenesis) (Moisa et al., 
2016). This signifies that examining miRNA abundance in tissues other than the liver would give 
us more insight into their biological impact. 
There were no differences observed in regard to treatment or time, and the interaction of 
treatment and time in miR-218, miR-200c, miR-142-3p, 142-5p, and mir-101, (Fig. 3.2). The 
lack of significant expression in miR-101 was unexpected since this was the only predicted 
miRNA to play a role in GSH metabolism (Table 3.1). Glutathione is a frequently studied 
antioxidant in cells because it maintains redox homeostasis (Forman et al., 2009). Methionine 
plays a role in one-carbon metabolism in liver and is a source of cysteine, the limiting reagent for 
synthesis of GSH (Martinov et al., 2010, Zhou et al., 2017). Although, there were no differences 
in miR-101 expression, miR-186, which was predicted to upregulate cysteine and methionine 
metabolism (Table 3.1), was expressed more in CON relative to MET at d 10. Since CON cows 
did not receive methionine they potentially would have upregulated cysteine and methionine 
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metabolism more so than MET cows. Perhaps, there is a relationship between cysteine and 
glutathione metabolism in the tested miRNA. However, experimentation is needed to further 
verify how these miRNAs regulate oxidative phosphorylation and fatty acid metabolism 
expression in liver or adipose tissue from cows supplemented methionine. 
CONCLUSIONS 
Overall, a decrease in the expression of miR-186, which is associated with 
downregulating fatty acid metabolism, in cows supplemented methionine suggests a relationship 
between pathways and miRNA in liver, compared with control cows. Analyses of gene targets 
and protein expression relevant to miR-186 and others presented in this study will provide more 





Figure 3.1. Biological importance of pathways involved in the etiology of fatty liver regulated 
by the activity of miRNAs predicted (in silico) to be activated during the onset of ketosis through 
feed restriction in liver of peripartal dairy cows. Length of the bar represents the entity impact, 
while grey denotes upregulate and black represents downregulation of the pathway. Adapted 
from Vailati-Riboni (2017). 
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Figure 3.2. Relative miRNA abundance for 8 miRNA targets in CON or MET treatments at -10, 
10, and 30 d relative to calving (least square means ± pooled SEM).  
 
*Means between treatments differ at the given time point (TRT x Time P < 0.05). 
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CHAPTER 4: BODY CONDITION SCORE IN LATE PREGNANCY IMPACTS 
HEPATIC BIOMARKERS OF ENERGY METABOLISM 
ABSTRACT 
We aimed to verify the expression miRNA in liver and evaluate any relationships they 
may have with oxidative phosphorylation and fatty acid metabolism. Additionally, our objective 
was to identify any associations between body condition score (BCS) in late-pregnancy, plasma 
biomarkers, and protein abundance linked to energy metabolism. Twenty-six multiparous 
Holstein dairy cows (n= 13/BCS group) were retrospectively selected according to BCS at 4 wk 
prepartum and divided into two treatments: HiBCS (BCS ≥ 3.50) or LoBCS (BCS < 3.25). In the 
prepartum, LoBCS cows had greater DMI compared to HiBCS cows (P = 0.06). In the 
postpartum, LoBCS continued to have greater DMI, but HiBCS cows averaged 5.34 kg/d greater 
in milk yield comparatively. Plasma sampled at d −30, −10, 7, 15, and 30, relative to calving 
indicated increased concentrations of biomarkers related to negative energy balance in HiBCS 
cows. In contrast, LoBCS had greater plasma concentrations of biomarkers that have antioxidant 
properties, thus suggesting a potential relationship with oxidative stress. Liver tissue harvested 
via biopsy at −15, 7, and 30 d relative to calving and used to evaluate protein abundance via 
western blotting. LoBCS cows had increased abundance of proteins associated with glutathione 
metabolism, an antioxidant that is capable of preventing overloads of reactive oxygen species 
(ROS), compared with HiBCS. miR-369 5p, miR-186, and miR-200b, which downregulate fatty 
acid metabolism and oxidative phosphorylation, had decreased expression in the liver of HiBCS 
cows, which is contrary to the patterns of decreased oxidative stress in LoBCS cows we observed 
in plasma biomarkers and protein abundance. In conclusion, the differences between production 
data, blood biomarkers, miRNA expression, and protein abundance underscore a potentially 
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important interaction between energy metabolism in relation to BCS during the periparturient 
period.    
INTRODUCTION 
 During the periparturient period dairy cows mobilize their adipose stores to meet 
lactation needs, at a time where dry matter intake (DMI) lags behind milk production, oftentimes 
creating a negative energy balance (NEB) and disrupting fatty acid metabolism (Drackley, 1999). 
When nutrient supply is depleted, adipose tissue mobilizes non-esterified fatty acids (NEFA) 
which originate from the hydrolysis of triacylglycerol (TAG) (Bell, 1995). Hepatic lipidosis 
results from excessive accumulation of TAG in the liver which ultimately impairs normal 
function.   
 Oxidative phosphorylation is essential for creating energy for various biological 
functions. However, it also produces reactive oxygen species (ROS) or free radicals, which can 
be destructive to an animal (Wallace et al., 1992). When the rate at which ROS can be removed 
or repaired becomes imbalanced, oxidative stress and inflammation begin. In nonruminants, 
nuclear factor erythroid 2-like 2 (NFE2L2) (formerly known as Nrf2), is a key transcription 
factor that controls oxidative stress by increasing the concentration of antioxidant enzymes, a 
mechanism of critical importance for cellular protection and survival (Kaspar et al., 2009). 
Glutathione (GSH), an antioxidant, reduces the levels of ROS to prevent free radical damage and 
its metabolism is one of the target pathways regulated by NFE2L2 (Bayir, 2005). In mammary 
epithelial cell culture, several antioxidants activate NFE2L2, causing an increase in the 
transcription of antioxidants overall (Jin et al., 2016). In summation, this suggests that both 
NFE2L2 and GSH, play a key role in regulating antioxidant networks. 
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  Importance has been placed on the quantification of the animal’s adipose reserves as a 
measure of animal health. Body condition score (BCS) is a useful tool as it evaluates both the 
amount of subcutaneous fat in the body and indicates the nutritional status of an animal (Roche 
et al., 2009). In the United States, BCS are evaluated on a 5-point scale, where 1 indicates a thin 
or emaciated cow, while a 5 equates to an over-conditioned obese cow (Roche et al., 2004). High 
BCS cows are at a greater risk of developing metabolic disorders and impaired immune function, 
compared to cows with lower body condition score cows (Reid et al., 1986, Bernabucci et al., 
2005b, Schulz et al., 2014). Therefore, BCS has a close relationship with metabolic disorders and 
is a useful tool in dairy cow management. 
microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression 
extensively (Iravani et al., 2018). Previous in silico work relevant to fatty liver disease and 
ketosis revealed miRNAs may play a role in fatty acid metabolism (miR-186, -200b, -369), 
oxidative phosphorylation (miR-186, -200b, -369), peroxisome (miR-186, -200b), 
gluconeogenesis (miR-186, -369), peroxisome proliferator-activator receptor (PPAR) signaling 
pathway (miR-186, -200b), insulin signaling pathway (miR-186, -200b, -369), and apoptosis 
(miR-200b, -369) (Vailati-Riboni, 2017). We aimed to verify the expression of these miRNA in 
liver and evaluate any relationships they may have with oxidative phosphorylation and fatty acid 
metabolism. Additionally, our objective was to identify any associations between body condition 
score (BCS) in late-pregnancy, plasma biomarkers, and protein abundance linked to energy 
metabolism. 
METHODS 
Experimental Design and Treatments 
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All procedures for this study were conducted in accordance with a protocol approved by 
the Institutional Animal Care and Use Committee at the University of Illinois (Urbana; protocol 
no. 17168). Twenty-six multiparous Holstein dairy cows (n= 13/BCS group) were 
retrospectively selected from a larger study that had 4 experimental treatments related to 1-
carbon metabolism. In the present study, cows were divided according to BCS at 4 wk prepartum 
and into two treatments: HiBCS (BCS ≥ 3.50, 3.75± 0.22, mean ± SD) or LoBCS (BCS < 3.25, 
3.07± 0.09, mean ± SD). BCS was evaluated weekly (-4 wk to 4 wk) by the mean score of 3 
trained observers on a 5-point scale. All cows had ad libitum access to the same diet; from -45 to 
-29 d cows were fed a typical Midwestern far-off diet, from −28 d to calving cows received a 
close-up diet (1.37 Mcal/kg of DM, 8.45% RDP, and 6.05% RUP), and from calving until 30 
DIM they received a lactation diet (1.65 Mcal/kg of DM, 11% RDP, and 6% RUP). More 
detailed ingredient and nutrient composition can be found in Table 4.1 and 4.2. Cows were fed as 
a total mixed ration (TMR) once daily (0700 h). Dry cows were housed in a free-stall barn with 
an individual Calan gate feeding system (American Calan, Northwood, NH, USA) and they had 
access to sand-bedded free stalls. After calving, cows were housed in a tie-stall barn and were 
fed a common lactation TMR in their individual feed bunks once daily in the morning, and 
milked 3 times daily (at 0500, 1300, 2300 h). DMI and milk yield were recorded daily. Diets 
were formulated to meet predicted requirements for dairy cows according to (NRC, 2001) 
Blood Collection and Analysis 
Blood was sampled from the coccygeal vein in the morning before cows had access to 
feed at d -30, -10, 7, 15, and 30 relative to calving. 13 cows in each treatment were used for 
analysis. Samples were collected into vacutainer tubes containing lithium heparin (BD 
Vacutainer, BD and Co., Franklin Lakes, NJ) and placed on ice. Plasma was obtained by 
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centrifugation at 2,000 x g for 15 min at 4°C and aliquots stored at -80°C until further analysis. 
Glucose, haptoglobin, myeloperoxidase, and ROM and γ-glutamyl transferase were analyzed 
using the IL Test purchased from Instrumentation Laboratory Spa (Werfen Co., Milan, Italy) in 
the ILAB 600 clinical auto analyzer (Instrumentation Laboratory, Lexington, MA). Fatty acids 
and BHB were measured using kits from Wako Chemicals (Richmond, VA) and Randox 
Laboratories Ltd. (Crumlin, United Kingdom), respectively, following the procedures described 
previously (Bionaz et al., 2007, Trevisi et al., 2012).  
Liver Biopsy 
 Liver tissue was sampled from 13 cows in each group on d -15, 7, and 30, relative to 
calving. A similar technique described previously by Vailati Riboni et al. (2015), was used to 
perform the biopsy. Briefly, the skin was shaved and disinfected and the skin and body wall were 
anesthetized with 7 mL of 2% lidocaine HCL (VetOne, Boise, ID). A stab incision was made 
through the skin in the right 11th intercostal space, through which an 18-gauge by 10.2-cm bone 
marrow probe (Monoject-8881-247087; Medtronic, Minneapolis, MN) was inserted into the liver 
and used to obtain approximately 4 g (wet weight) of liver. No more than three separate 
penetrations with the biopsy probe were performed. Samples were snap frozen in liquid nitrogen, 
and subsequently stored at -80°C. Health was monitored for 7 d after each procedure.  
Western Blot Analysis 
Total protein was extracted from (~0.05 g) of liver tissue using a tissue protein extraction 
reagent (catalog no. 78510; Thermo Fisher Scientific) containing Halt protease and phosphatase 
inhibitor cocktail (100×, catalog no. 78442; Thermo Fisher Scientific). The concentration of total 
protein was determined using a Nano-Drop ND-1000 spectrophotometer (Nano-Drop 
Technologies, Wilmington, DE, USA). Protein samples were denatured by heating at 95°C for 5 
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min before loading 75 µg of protein into each lane of a 4–20% SDS-PAGE gel (catalog no. 
4561096; Bio-Rad, Hercules, CA). Reactions were run for 10 min at 180 V, and then for 45 to 60 
min at 110 V. After activating a polyvinylidene fluoride membrane (catalog no. 1620261; Bio-
Rad) with methanol for 1 min, the protein sample was transferred to the membrane in a Trans-
Blot SD Semi-Dry Electrophoretic Transfer Cell (catalog no. 170-3940; Bio-Rad). Membranes 
were then blocked in 1× Tris-buffered saline (TBST) containing 5% nonfat milk for 2 h at room 
temperature. The membranes were then incubated in 1× TBST containing primary antibodies to 
glutathione peroxidase 3 (GPX3), glutathione S-transferase mu 1 (GSTM1), glutathione S-
transferase α 4 (GSTA4), NFE2L2, and phospho-NFE2L2 (Ser40) [catalog number and dilution 
ratio are included in Supplemental Table B.1. (Appendix B)] overnight at 4°C. The membranes 
were then washed 6 times with 1× TBST and incubated with anti-rabbit horseradish peroxidase-
conjugated secondary antibodies (catalog no. 7074S; dilution 1:2,000; Cell Signaling 
Technology, Danvers, MA) for 1 h at room temperature. Subsequently, the membranes were 
washed 6 times with 1× TBST and then incubated with enhanced chemiluminescence reagent 
(catalog no. 170-5060; Bio-Rad) for 3 min in the dark prior to image acquisition. GAPDH 
(catalog no. 2118S; Cell Signaling Technology) was used as the internal control. Images were 
acquired using the ChemiDOC MP Imaging System (Bio-Rad). The intensities of the bands were 
measured with Image-Pro Plus 6.0 software (Media Cybernetics, Rockville, MD). Specific target 
protein band density values were normalized to GAPDH density values. Representative blots are 
included in Supplemental Figure B.1. (Appendix B). 
Total RNA Extraction, Target miRNA, and qPCR 
RNA was extracted from tissue using protocols established in our laboratory (Khan et al., 
2014). Briefly, liver tissue was weighed (~0.05 g) and immediately placed in 1.2 ml of QIAzol 
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reagent (Qiagen 75842; Qiagen Inc., Valencia, CA) for homogenization. After homogenization, 
DNase was used to remove any genomic DNA from RNA using RNeasy Mini Kit columns 
(Qiagen, Hilden, Germany). Concentration was measured using the Nano-Drop ND-1000 
spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA), and the Agilent 
Bioanalyzer system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA) 
was used to measure RNA quality. miRNA-specific cDNA synthesis was performed using the 
Quanta qScript microRNA cDNA Synthesis Kit (Quanta BioSciences, Inc.), following the 
manufacturer’s protocols. The quantitative PCR (qPCR) was SYBR Green-based and performed 
as described previously by Osorio et al. (2014), using a 7-point standard curve. miRNA selected 
for expression profiling were miR-369 5p, miR-186, and miR-200b, because previous research 
found they are involved in a variety of biological pathways, verified by being expressed in liver 
tissue (Bucktrout, unpublished 2018, Vailati-Riboni et al., 2015). The final data were normalized 
using the geometric mean of, miR-let-7b, miR-16b and miR-181a, which served as the internal 
controls. Measured miRNA assay primer sequence information and qPCR performance are 
included in Supplemental Table B.2. and B.3. (Appendix B). Percentage relative miRNA 
abundance in relation to the 3 miRNA targets is in Supplemental Figure B.2. (Appendix B)  
Statistical Analysis 
Data were log2 transformed prior to statistical analysis to obtain a normal distribution. 
Statistical analysis was performed using the MIXED procedure of SAS v.9.4 (SAS Institute Inc., 
Cary, NC) according to the following model with repeated measures:  
Yjl = µ + Mj + Tl + MTjl + ejl, 
Where Yjl = dependent, continuous variable, µ = overall mean, Mj = fixed effect of treatment (j = 
HiBCS vs. LoBCS), Tl = fixed effect of time, MTjl = interaction between treatment and time, and 
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ejl = residual error. Cow, nested within treatment, was the random effect. The production data 
were analyzed separately for the prepartum (d -28 to -1) and postpartum (from 1 to 30 d 
postpartum) periods. The exponential correlation covariance structure [SP(POW)] for repeated 
measures was used in analysis where time intervals are not evenly spaced such as blood 
biomarkers, miRNA abundance, and protein abundance. The covariance structure [(AR)(1)] was 
used for analysis when time was evenly spaced such as, DMI and milk yield. The Kenward-
Roger statement was used for computing the denominator degrees of freedom. Data were 
considered significant at a P ≤ 0.05 and tendencies at P ≤ 0.10 using the PDIFF statement in 
SAS. For ease of interpretation, data reported in tables and figures are the log2 back-transformed 
LSM that resulted from the statistical analysis. Normality of the residuals was checked with 
normal probability and box plots, and homogeneity of variances was checked with plots of 
residuals versus predicted values.  
RESULTS AND DISCUSSION 
Dry Matter Intake and Milk Production 
 In the prepartum, LoBCS cows had greater DMI compared to HiBCS (P =0.06) (Fig. 
4.1). Overall, both groups of cow’s DMI gradually declined in the 3 weeks before parturition. 
HiBCS had a steeper decline in DMI, perhaps suggesting they were more inclined to enter NEB 
after pregnancy, compared with LoBCS. Many authors report a decrease in DMI before calving, 
most likely due cows entering NEB, reduced rumen volume, and hormonal responses to 
pregnancy (Zhou et al., 2016, Batistel et al., 2017, Alharthi et al., 2018). Despite the fact that 
BCS is linked with the metabolic response to lactation and its level is regulated through nutrition, 
cows with different levels of adipose deposits are generally managed similarly during the 
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prepartum period. For a producer to divide cows based on BCS before calving and design 
different diets based on energy requirements seems unpractical. However, it would be interesting 
to examine if the incidence of metabolic disorders in the postpartum decrease.  
In the immediate 2 weeks after calving, LoBCS cows had greater DMI compared to 
HiBCS cows (P ≤ 0.05) (Fig. 4.2). As both treatments approached around twenty DIM, there 
were no major differences in DMI through the remainder of the transition period. This is 
consistent with the literature since cows with higher body condition scores tend to eat less 
postpartum, thus receive less energy supply compared to low body condition score cows (Roche 
et al., 2008). Thereby causing a ripple effect to increase tissue mobilization of NEFA to the liver, 
leading to a greater risk of developing metabolic disorders like ketosis and fatty liver in the 
postpartum (Cameron et al., 1998). 
Overall milk production was 5.34 kg/d greater (P ≤ 0.05) in HiBCS compared with 
LoBCS cows (Fig. 4.3). The effect of BCS on milk yield in the literature is conflicting. Many 
authors report a negative relationship between BCS and milk yield (Roche et al., 2009). Though 
HiBCS had less intake before and after calving, they produced more milk suggesting they were 
in an even greater NEB than predicted. Another study found that high BCS cows (BCS = 4.00 ± 
0.20) had greater milk yield compared with medium BCS cows (BCS = 3.25 ± 0.25) from 
calving to 180 DIM (Zahrazadeh et al., 2018). Similarly, cows grouped by high BCS (5.5) and 
medium BCS (4.5) had greater milk yield than low BCS cows (3.5) surrounding parturition 
(Akbar et al., 2015). Although, Zhao et al. (2019), found that there is no difference in milk yield 
among medium BCS (3.0-3.25), high BCS (3.5-3.75), higher BCS (4.0-4.25), and highest BCS 
(4.5-5.0) cows during the first 100 DIM. However, it is likely that the differences between 
studies are caused by the length of DIM observed and different BCS cut-offs for high vs. low. 
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Future studies could explore a treatment design that span high, optimal, and low BCS intervals. 
Plasma Biomarkers 
Cows in HiBCS had greater overall plasma concentrations of biomarkers relevant to 
energy balance such as NEFA (P ≤ 0.05) and a tendency for increased BHBA (P = 0.07), 
compared to LoBCS (Table 4.3). It is well established that cows with higher BCS and greater 
BCS loss have increased concentrations of NEFA and BHBA, making them sensitive to 
oxidative stress (Rukkwamsuk et al., 1998, Bernabucci et al., 2005a). We observed a similar 
trend whereby, HiBCS before calving were still greater conditioned than LoBCS throughout -4 
to 4 wk (Fig. 4.5). However, HiBCS had around 0.44 greater BCS loss compared to LoBCS 
cows when comparing only wk -4 to wk 4 (Fig. 4.6). Furthermore, myeloperoxidase, a biomarker 
involved in inflammation, had greater plasma concentrations in HiBCS (P ≤ 0.05) (Table 4.3). 
Our results are consistent with another study that found energy partitioning between peripheral 
tissues likely increases plasma NEFA and lipid peroxidation, but may reduce the antioxidant 
capacity of high producing dairy cows (Castillo et al., 2005). The higher concentration of 
biomarkers that contribute to energy balance and inflammation in HiBCS cows may suggest that 
they are experiencing a NEB. 
LoBCS had greater overall plasma concentrations of an inflammation biomarker, alkaline 
phosphatase, including greater concentrations at d -30 and -10 relative to calving compared to 
HiBCS cows (P ≤ 0.05) (Fig. 4.4). However, myeloperoxidase, another biomarker involved in 
inflammation, had greater plasma concentrations in HiBCS (P ≤ 0.05) (Table 4.3). It is plausible 
that both HiBCS and LoBCS have greater concentrations of inflammation biomarkers because of 
the increased energy demands surrounding calving.  
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β-carotene is a lipid soluble antioxidant that plays an important role in health and 
immunity in transition cows (Spears and Weiss, 2008). We found that β-carotene (P ≤ 0.05) had 
greater overall plasma concentrations in LoBCS vs. HiBCS, and concentrations were greatest at 
d -30 and -10 relative to calving (P ≤ 0.05) compared with HiBCs cows (Fig. 4.4). Tocopherol 
plasma concentrations were greater (P ≤ 0.05) in LoBCS vs. HiBCS cows, marked by greater 
concentrations at d -30 and 15 in LoBCS cows (Fig. 4.4). β-carotene and tocopherol work in 
synergy as antioxidants to reduce oxidative stress (Ryan et al., 2010). FRAP is another indicator 
of antioxidant, or reducing ability, in oxidative stress (Benzie and Strain, 1996). We observed 
that LoBCS cows FRAP concentration had a tendency (P = 0.06) to be greater at 30 d relative to 
calving compared with HiBCS (Fig. 4.4). This suggests that compared to HiBCS cows, LoBCS 
were under less oxidative stress.   
Protein Abundance  
We were unable to detect any protein abundance of nuclear factor erythroid 2-like 2 
(NFE2L2) or p-NFE2L2 (both are involved in antioxidant signaling pathways) at any time point 
or treatment in liver tissue as represented by blots in Supplemental Figure B.1 (Appendix B). 
This could be attributed to the fact that in western blotting we use antibodies that are guaranteed 
to react in human, mouse and rat models, but are only predicted to react in cows. Most work 
involving NFE2L2 in cows is focused on the gene networks in mammary tissue (Han et al., 
2018, Ma et al., 2018). In adipose tissue genes related to NFE2L2 are highly upregulated in liver 
tissue (Liang et al., 2019). 
The enzymes GSTM1, GSTA4, and GPX3 play essential roles in inactivating pro-oxidant 
products such as H2O2 and oxygen radicals in various tissues (Lee et al., 2008, Curtis et al., 
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2010). Protein abundance of GSTM1 had a significant treatment by time interaction, namely due 
to greater abundance in LoBCS cows at d -15 relative to calving, compared to HiBCS (P ≤ 0.05) 
(Fig. 4.7). Furthermore, GSTM1 overall abundance tended to be greater in LoBCS at d-15 and 7, 
but not 30. (P = 0.08) (Fig. 4.7). Though the protein abundance of GSTA4 did not have a 
significant relationship between treatment and time, LoBCS had overall greater abundance 
compared with HiBCS (P ≤ 0.05) (Fig. 4.7). The glutathione-S-transferase enzyme family 
includes GSTM1 and GSTA4 which are considered to be important for detoxification of 
electrophiles via GSH conjugation (Strange et al., 2001). LoBCS cows had greater abundance of 
GPX3 compared to HiBCS (P ≤ 0.05) (Fig. 4.7). In obese mice, GPX3 protein expression was 
downregulated which was speculated to increase ROS accumulation, leading to oxidative stress 
and metabolic disorders (Lee et al., 2008). Overall, protein abundance of 4 GSH-related targets 
increased in LoBCS liver, suggesting a decrease in oxidative stress, as opposed to HiBCS.  
miRNA Expression 
miR-186 expression had no detectable changes in the relationship between treatment and 
time effect (P = 0.43) (Fig. 4.8). This miRNA was predicted to play a role in the downregulation 
of fatty acid metabolism, which is relevant to cows with varying BCS during parturition as they 
try to meet their energy needs. Furthermore, these results were unexpected given that our 
previous unpublished work found decreased miR-186 expression in cows supplemented rumen-
protected methionine, thus implying less fatty acid metabolism in the liver, compared to control 
cows. Although no detectable changes were found in the liver for this miRNA, adipose tissue 
expression could be an area for future study. Another study in beef cattle found that miR-186 
was expressed at higher levels in adipose tissue from low backfat thickness animals, compared to 
high backfat thickness animals, suggesting that miRNA may have a role in adipogenesis and/or 
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lipid deposition in tissue (Jin et al., 2010). This underscores the need for more experimentation 
on miRNAs involved in energy metabolism in cows with varying levels of adipose deposits 
(BCS). 
Abundance of miR-200b had a treatment by time effect (P ≤ 0.05) due to a marked 
upregulation between −15 and 7 d followed by increased abundance at 30 d in cows with LoBCS 
(Fig. 4.8). miR-200b was predicted to downregulate both fatty acid metabolism and oxidative 
phosphorylation (Vailati-Riboni, 2017). miR-369 5p was predicted to play a role in upregulating 
fatty acid metabolism and downregulating oxidative phosphorylation (Vailati-Riboni, 2017). 
Expression of miR-369 5p was lower (P ≤ 0.05) overall in cows with HiBCS (Fig. 4.8). Overall, 
miR-369 5p and -200b were both predicted to downregulate fatty acid metabolism. Some would 
infer that since they were downregulated in HiBCS liver, the tissue potentially has less fatty 
acids, which could suggest less incidence of NEB or oxidative phosphorylation. However, fatty 
acid metabolism encompasses both the degradation and synthesis of fatty acids. A cow could 
have a significant capacity for fat mobilization and still have no incidence of the negative health 
effects we observe in dairy cows surrounding parturition and vice versa.   
Oxidative phosphorylation is essential in energy metabolism, but it increases ROS which 
can damage DNA, proteins, and lipids. Antioxidants, like glutathione, reduce the levels of ROS 
to prevent free radical damage (Bayir, 2005). When the rate at which ROS can be removed or 
repaired becomes imbalanced, oxidative stress begins. Intuitively speaking, when oxidative 
phosphorylation is downregulated in HiBCS they may be under less oxidative stress. However, 
the findings that miR-369 5p and -200b expression suggest are inconsistent with the other 
parameters examined in the present study, as we observed protein abundance and plasma 
biomarkers suggest a decrease in oxidative stress in LoBCS compared to HiBCS cows. Overall, 
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research on miRNA biomarkers is still a developing field, especially considering the vast 
majority of studies are in non-ruminant models. It is also important to recall that the miRNA 
functions in biological pathways were predicted in silico, which holds many limitations 
compared with in vivo studies. This underscores the importance of more experimentation 
examining how miRNAs work in regulating biological processes like fatty acid metabolism, as 
some results are conflicting.   
CONCLUSIONS 
Cows with less BCS had increased intake in the postpartum and immediately after 
calving compared to high BCS cows. Additionally, plasma biomarkers and protein abundance 
may suggest LoBCS are under less oxidative stress than HIBCS cows. Predicted miRNA 
potentially play a role in energy metabolism. Future in vitro studies using hepatocytes may help 
us to better understand the role and mechanisms for these responses.  
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TABLES AND FIGURES 
 
Table 4.1. Ingredient composition of diets fed to HiBCS and LoBCS cows during close-up (−28 
d to calving), and early lactation (calving to 30 d) periods. 
 
Ingredient (% of DM) Close-up Lactation 
Corn silage 37.47 41.18 
Ground shelled corn - 23.95 
Wheat straw 36.60 2.30 
Canola Meal 11.67 3.25 
Soybean meal 6.30 13.12 
Alfalfa hay - 8.70 
Soychlor 3.37 - 
Corn gluten  2.80 2.50 
Mineral Mix  0.53 4.1 
Calcium sulfate 0.53 - 
ProvAAL2 AADvantage 0.47 0.73 
 49 
Table 4.2. Nutrient composition of prepartal and postpartal diets fed to HiBCS and LoBCS cows 
during the peripartal period. 
 
Chemical component Close-up Lactation 
NEl Mcal/kg 1.37 1.65 
CP (% of DM) 14.50 17.00 
RUP (% of DM) 6.05 6.00 
RDP (% of DM) 8.45 11.00 
NDF Forage (% of DM) 43.30 21.50 
ADF (% of DM) 33.80 16.76 
aNDFom (% of DM) 49.21 27.01 
Starch (% of DM) 13.75 30.00 
Sugar (% of DM) 5.00 4.76 
Ca (% of DM) 0.66 1.00 
P (% of DM) 0.33 0.35 
Salt (% of DM) 0.10 0.25 
Na (% of DM) 0.12 0.45 
Cl (% of DM) 0.78 0.68 
Mg (% of DM) 0.45 0.38 
K (% of DM) 1.36 1.45 






Table 4.3. Least square means and pooled SEM for plasma biomarkers in cows grouped into HiBCS and LoBCS at -30, -10, 7, 15, 
and 30 d relative to calving. 







Parameter1 HiBCS LoBCS SEM -30 -10 7 15 30 SEM Treatment Time Trt*time 
Energy Balance             
β-hydroxybutyrate, mmol/L 0.68 0.59 0.04 0.44 0.46 0.87 0.73 0.79 0.06 0.07 <.01 0.76 
Glucose, mmol/L 4.12 4.09 0.05 4.54 4.50 3.74 3.84 3.88 0.07 0.70 <.01 0.79 
NEFA, mmol/L 0.50a 0.38b 0.04 0.11 0.26 0.99 0.80 0.66 0.10 0.03 <.01 0.37 
Liver Function             
AST, U/L 92.78 103.98 4.74 88.71 75.21 123.38 115.82 95.88 6.13 0.09 <.01 0.86 
Bilirubin, µmol/L 2.77 2.23 0.42 0.54 1.11 7.57 5.47 3.84 1.16 0.31 <.01 0.98 
Cholesterol, mmol/L 2.78 3.20 0.20 3.23 2.77 2.02 2.89 4.03 0.16 0.14 <.01 0.62 
GGT, U/L 22.68 21.32 1.34 4.47 4.26 4.26 4.63 4.68 0.09 0.46 <.01 0.61 
Paraoxonase, U/mL 80.98 84.07 4.33 93.92 86.50 66.54 77.00 88.66 4.06 0.61 <.01 0.60 
Inflammation             
Alkaline phosphatase, U/L 46.69b 58.43a 4.18 50.98 50.25 56.58 53.69 49.95 3.54 0.04 0.05 0.01* 
Albumin, g/L 36.30 36.11 0.35 36.61 36.13 35.53 36.14 36.62 0.37 0.71 0.06 0.51 
Ceruloplasmin, µmol/L 2.94 2.92 0.08 2.50 2.46 3.23 3.26 3.18 0.08 0.89 <.01 0.52 
Haptoglobin, g/L 0.32 0.30 0.02 0.27 0.28 0.50 0.33 0.24 0.04 0.33 <.01 0.79 
Myeloperoxidase, U/L 512.57a 473.12b 12.10 463.90 490.09 536.69 508.69 464.85 15.69 0.03 <.01 0.25 
Oxidative Stress             
FRAP, µmol/L 117.06 121.84 2.50 114.28 107.55 127.50 126.82 122.24 3.55 0.18 <.01 0.06* 
ROM, H2O2/100 mL 14.67 14.47 0.31 13.47 13.01 15.76 15.53 15.08 0.38 0.64 <.01 0.80 
β-carotene, mg/100 mL 0.20b 0.26a 0.02 0.35 0.29 0.14 0.15 0.21 0.02 0.03 <.01 0.01* 
Retinol, µg/mL 27.25 30.08 1.74 33.69 28.39 22.04 26.76 32.45 1.66 0.26 <.01 0.30 
Tocopherol, µg/mL 3.20b 3.83a 0.20 4.12 3.36 2.37 3.20 4.50 0.22 0.03 <.01 <.01* 
             *Means between treatments differ at a specific time point (TRT x Time P < 0.05, Tendency P < 0.10) (See Fig. 4.4). 
a,b Means between treatments differ (TRT P < 0.05). 
1NEFA = non-esterified fatty acids, AST = aspartate aminotransferase, GGT = γ-glutamyl transferase, FRAP = ferric-reducing ability 




Figure 4.1. Dry matter intake (DMI) as % body weight (BW) (least square means ± pooled 





Figure 4.2. Dry matter intake (DMI) as % body weight (BW) (least square means ± pooled 
SEM) of HiBCS and LoBCS cows during early lactation (1 to 30 days relative to calving). 
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Figure 4.3. Milk yield (kg/d) (least square means ± pooled SEM) of HiBCS and LoBCS cows 
from 1 to 30 days relative to parturition. 
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Figure 4.4 Plasma concentrations of indicators of inflammation (alkaline phosphatase) and 
oxidative stress (FRAP1, β-carotene, and tocopherol) in HiBCS vs. LoBCS cows at -30, -10, 7, 
15, and 30 d relative to parturition (least square means ± pooled SEM). 
 
a,b Means between treatments differ at the given time point (TRT x Time P < 0.05, Tendency P < 
0.10). 
1FRAP = ferric-reducing ability of plasma 
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Figure 4.5. Body condition scores (BCS) from -4 wk to 4 wk relative to calving in HiBCS and 
LoBCS cows.  
 
* indicates a significant treatment by week effect (P ≤ 0.05). 
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Figure 4.6. Change in body condition score (BCS) on a 5-point scale from -4 wk to 4 wk relative 
to calving in HiBCS and LoBCS cows.  
 
* indicates significant differences (P ≤ 0.05). 
 57 
 
Figure 4.7. Protein abundance (relative to GAPDH) of glutathione metabolism-related enzymes 
(GSTM1 = glutathione S-transferase mu 1; GSTA4 = glutathione S-transferase α 4; GPX3 = 
glutathione peroxidase 3) in liver tissue harvested from HiBCS and LoBCS cows at -15, 7, and 
30 d relative to parturition (least square means ± pooled SEM).  
 




Figure 4.8. Relative miRNA abundance for 3 miRNA targets in HiBCS and LoBCS cows at -15, 
7, and 30 d relative to calving (least square means ± pooled SEM).  
 
*Means between treatments differ at the given time point (TRT x Time P < 0.05). 
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CHAPTER 3-SUPPLEMENTAL MATERIAL 
 
Supplemental Table A.1. Measured microRNA assay primer sequence information. A PerfeCTa 
Universal PCR Primer (Quanta BioSciences, Inc.) was coupled to the assay primer for 




miR-369 5p ATCGACCGTGTTATATTCGC 
miR-200b TAATACTGCCTGGTAATGATG 
miR-200c TAATACTGCCGGGTAATGATGGA 
miR-142 3p AGTGTTTCCTACTTTATGGATG 




Supplemental Table A.2.  qPCR performance of measured miRNAs. 
Target Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
miR-218 24.96 6.04 -3.367 0.995 1.982 
miR-369 5p 29.28 10.28 -3.363 0.993 1.983 
miR-200b 21.17 2.18 -3.437 0.999 1.954 
miR-200c 22.46 3.50 -3.315 0.999 2.003 
miR-142 3p 23.24 4.16 -3.375 0.999 1.978 
miR-142 5p 23.16 4.20 -3.382 0.995 1.976 
miR-101 18.06 -0.91 -3.207 0.997 2.050 
miR-186 19.20 0.18 -3.477 0.998 1.939 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls] for each time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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Supplemental Figure A.1. Percentage relative miRNA abundance1 in relation to 8 miRNA 
targets. 
1relative miRNA abundance = 1/ Efficiency Median ∆Ct   ,1/E∆Ct = relative miRNA 
abundance/∑relative mRNA abundance. 
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APPENDIX B 
CHAPTER 4-SUPPLEMENTAL MATERIAL 
 
Supplemental Table B.1. Antibody symbol, catalog number, company, dilution ratio, and 
antibody name for antibodies measured in liver tissue from periparturient dairy cows.   
Antibody Catalog Number Company Dilution 
ratio 
Antibody Name 
GSTM1 ARP41769_P050 Aviva Systems 
Biology 
1:250 Glutathione S-
transferase Mu 1 













erythroid 2-like 2 
Phospho-
NFE2L2(Ser40) 






erythroid 2-like 2 
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Supplemental Table B.2. Measured microRNA assay primer sequence information. A PerfeCTa 
Universal PCR Primer (Quanta BioSciences, Inc.) was coupled to the assay primer for 
expression analysis via qPCR. 
miRNAs Sequence 





Supplemental Table B.3. qPCR performance of measured microRNAs. 
Target Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
miR-369 5p 30.27 11.09 -3.387 0.985 1.974 
miR-186 18.92 -0.28 -3.474 0.998 1.940 
miR-200b 22.72 3.42 -3.353 0.991 1.987 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls] for each time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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            Target1                          HiBCS                        LoBCS   
GAPDH, 37 kDa             
GSTM1, 26 kDa        
GSTA4, 26 kDa               
GPX3, 25 kDa       
NFE2L2, 100-130 kDa    
p-NFE2L2, 90-100 kDa   
Supplemental Figure B.1. Representative blots with band size information. NFE2L2 and p-
NFE2L2 were undetected at all time points. 
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Supplemental Figure B.2. Percentage relative miRNA abundance1 in relation to 3 miRNA 
targets. 
1relative miRNA abundance = 1/ Efficiency Median ∆Ct   ,1/E∆Ct = relative miRNA 
abundance/∑relative mRNA abundance. 
 
 
